Leptin polymorphism rs3828942: risk for anxiety disorders?
- 11 Downloads
Leptin is an anorexigenic hormone well recognized by its role in mediating energy homeostasis. Recently, leptin has been associated with psychiatric disorders and interestingly, leptin treatment has shown antidepressant and anxiolytic effects. We examined the association of leptin levels and leptin (LEP) gene rs3828942 polymorphism with anxiety disorders considering sex differences. A cross-sectional population-based study, including 1067 young adults, of whom 291 presented anxiety disorders diagnosed by the Mini International Neuropsychiatric Interview (MINI 5.0). The rs3828942 polymorphism was genotyped by real-time PCR and ELISA measured leptin levels. Leptin levels were not associated with anxiety disorders after adjusting for sex and body mass index (BMI) [ß = − 0.009 (− 0.090–0.072); p = 0.832]. The distribution of rs3828942 genotypes was not associated with anxiety disorders. However, in a sex-stratified sample, the A-allele of rs3828942 polymorphism was associated with risk for GAD in women even when adjusting for confounding variables [OR = 1.87 (1.17–2.98); p = 0.008]. In a subsample of 202 individuals with GAD and control matched by sex and BMI, results suggest an interaction between genotypes and GAD diagnosis based on leptin levels only in the male group [F (1, 54) = 6.464; p = 0.0139]. Leptin is suggested to be related with the neurobiology of anxiety disorders in a sex-dependent manner since women carrying the A-allele of LEP rs3828942 present a higher risk for GAD, while leptin levels seem to be lower in men with GAD carrying A-allele. Studies on the relationship between leptin polymorphisms and levels are scarce and, therefore, further research is necessary.
KeywordsLeptin Leptin polymorphism Anxiety disorders Generalized anxiety disorder
We would like to thank Editage (http://www.editage.com) for English language editing.
All authors mentioned in the paper have significantly contributed to the research. RAS, KJ, LDS, and DRL conceived and supervised the clinical evaluation. MPK and GG supervised the collection and processing of biological samples. PVS, CRB, and AP performed the DNA extraction and genotyping and MG and PVS performed leptin level measurements. PVS, CRB, APA, AP, GG, and MPK performed statistical analysis and wrote the manuscript.
This study was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Ensino Superior (CAPES) and PRONEX-FAPERGS (08/2009 - Pronex 10/0055-0). RS, KJ, LDS, MPK, and DRL are CNPq Research Fellows. PVS, CRB, and APA received a fellowship from CAPES.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interests.
Statement of ethics
The study protocol was approved by the Ethics Committee of Catholic University of Pelotas, Pelotas, Brazil (Protocol number 2010/15). All participants signed the written informed consent.
- 1.World Health Organization (2017) Depression and other common mental disorders: global health estimates. License: CC BY-NC-SA 3.0 IGO. http://www.who.int/iris/handle/10665/254610. Accessed 10 Jan 2019
- 2.American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric PubGoogle Scholar
- 4.Kessler RC, Ormel J, Demler O, Stang PE (2003) Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J Occup Environ Med 45:1257–1266. https://doi.org/10.1097/01.jom.0000100000.70011.bb CrossRefGoogle Scholar
- 6.Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S et al (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–19. https://doi.org/10.1001/archpsyc.1994.03950010008002 CrossRefGoogle Scholar
- 27.Milaneschi Y, Lamers F, Bot M, Drent ML, Penninx BW (2017) Leptin dysregulation is specifically associated with major depression with atypical features: evidence for a mechanism connecting obesity and depression. Biol Psychiatry 81:807–814. https://doi.org/10.1016/j.biopsych.2015.10.023 CrossRefGoogle Scholar
- 30.Brandl EJ, Frydrychowicz C, Tiwari AK, Lett TAP, Kitzrow W, Büttner S et al (2012) Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain. Prog Neuro-Psychopharmacol Biol Psychiatry. https://doi.org/10.1016/j.pnpbp.2012.03.001 Google Scholar
- 32.Gregoor JG, van der Weide J, Loovers HM, van Megen HJ, Egberts TC, Heerdink ER (2010) Association between LEP and LEPR gene polymorphisms and dyslipidemia in patients using atypical antipsychotic medication. Psychiatr Genet 20:311–316. https://doi.org/10.1097/YPG.0b013e32833b6378 CrossRefGoogle Scholar
- 45.Kloiber S, Ripke S, Kohli MA, Reppermund S, Salyakina D, Uher R et al (2013) Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels. Eur Neuropsychopharmacol 23:653–662. https://doi.org/10.1016/j.euroneuro.2012.08.010 CrossRefGoogle Scholar